Princeton Capital Management LLC Aerie Pharmaceuticals Inc Transaction History

Princeton Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$9.12 - $14.49 $95,413 - $151,594	-10,462 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$12.0 - $16.13 $125,544 - $168,752	10,462 New	10,462 $154,000
Q4 2019 Feb 12, 2020	SELL	$17.72 - $25.1 $58,298 - $82,579	-3,290 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $29,456 - $44,800	1,600 Added 94.67%	3,290 $63,000
Q2 2019 Aug 12, 2019	BUY	$28.97 - $48.21 $48,959 - $81,474	1,690 New	1,690 $50,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Princeton Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Princeton Capital Management LLC with notifications on news.